← All sarcoma trials
Recruiting nowN/AAges 18 Years to 75 Years

Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy

Sponsor: N.N. Petrov National Medical Research Center of Oncology · NCT04330456 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Soft Tissue Sarcoma Adult

What it tests

  • Preoperative stereotactic radiation therapy in hypofractionation moderadiation
  • Surgeryprocedure
  • Postoperative conformal radiation therapy in normofractionation moderadiation

Where it's running1 site

1 international site

  • National Research Center of Oncology named after N.N.Petrov

    Saint Petersburg, Russia

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* morphologically verified diagnosis of soft tissue sarcoma
* first diagnosed tumor process
* ability to perform radical surgery
* signed informed consent
* indications for stereotactic and conformal radiation therapy
* no contraindications for radiation and surgical treatment

Exclusion Criteria:

* previous radiation treatment
* acute infection
* pregnancy, lactation
* recurrent tumor
* refuse to sign informed consent
* conditions that can affect the outcome of treatment (immunodeficiency, tuberculosis, etc.)
* tumor topography and volume that don't allow to perform stereotactic and conformal radiation therapy.

Updated 2020-04-01 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.